Is Seizure an Adverse Effect of Salbutamol in the Pediatric Population?

Basit Öğe Kaydı
dc.authoridÖzünal, Zeynep güneş/0000-0002-3060-1507en_US
dc.authoridYILDIZ, Raif/0000-0003-1636-1241en_US
dc.contributor.authorUysalol, Metin
dc.contributor.authorYıldız, Raif
dc.contributor.authorGüneş Özünal, Zeynep
dc.date.accessioned2024-07-12T21:37:45Z
dc.date.available2024-07-12T21:37:45Z
dc.date.issued2022en_US
dc.department[Belirlenecek]en_US
dc.description.abstractBackground: Although studies on epileptic seizures occurring during acute asthma attacks are limited, there is widespread belief among families and physicians that salbutamol causes seizures. Aims: To investigate whether salbutamol triggers seizures in patients with epilepsy and asthma.Study Design: A retrospective cohort study.Methods: Epilepsy and asthma in patients aged 2-18 years who were admitted to the pediatric emergency department because of asthma attacks between January 2016 and December 2016 in a university hospital were evaluated retrospectively. The inclusion criteria were age 2-18 years, previous diagnosis of epilepsy and asthma, and admission to the pediatric emergency department due to asthma attacks.Results: 276 medical records were evaluated. The seizure group had a longer period of diagnosis for epilepsy than the seizure absent group in the pediatric emergency department (5.4 years and 3.1, respectively). According to the logistic regression analysis, the duration of seizures in the emergency department, duration of asthma diagnosis, duration of epilepsy diagnosis, uncontrolled asthma, and severity of asthma attack in the pediatric emergency department have significantly increased the possibility of having a seizure during an asthma attack in our study population.Conclusion: This study shows that patients using salbutamol have a lower risk of epileptic seizures than those who do not use salbutamol. This result should be verified by studies containing a large number of patients.en_US
dc.identifier.doi10.4274/balkanmedj.galenos.2022.2022-3-103
dc.identifier.endpage344en_US
dc.identifier.issn2146-3123
dc.identifier.issn2146-3131
dc.identifier.issue5en_US
dc.identifier.pmid35844116en_US
dc.identifier.scopus2-s2.0-85137802763en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage340en_US
dc.identifier.trdizinid1132451en_US
dc.identifier.urihttps://doi.org/10.4274/balkanmedj.galenos.2022.2022-3-103
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/1132451
dc.identifier.urihttps://hdl.handle.net/20.500.12415/6925
dc.identifier.volume39en_US
dc.identifier.wosWOS:000860479400006en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherGalenos Publ Houseen_US
dc.relation.ispartofBalkan Medical Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmzKY04267
dc.titleIs Seizure an Adverse Effect of Salbutamol in the Pediatric Population?en_US
dc.typeArticle
dspace.entity.typePublication

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu